BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36279669)

  • 1. Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer.
    Gao L; Jiang W; Yue Q; Ye R; Li Y; Hong J; Zhang M
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109335. PubMed ID: 36279669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT radiomics prediction of CXCL9 expression and survival in ovarian cancer.
    Gu R; Tan S; Xu Y; Pan D; Wang C; Zhao M; Wang J; Wu L; Zhao S; Wang F; Yang M
    J Ovarian Res; 2023 Aug; 16(1):180. PubMed ID: 37644593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer.
    Zhan F; He L; Yu Y; Chen Q; Guo Y; Wang L
    Sci Rep; 2023 Sep; 13(1):16397. PubMed ID: 37773310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas.
    Yoon J; Suh YJ; Han K; Cho H; Lee HJ; Hur J; Choi BW
    Thorac Cancer; 2020 Apr; 11(4):993-1004. PubMed ID: 32043309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.
    Zhuang Z; Liu Z; Li J; Wang X; Xie P; Xiong F; Hu J; Meng X; Huang M; Deng Y; Lan P; Yu H; Luo Y
    J Transl Med; 2021 Jun; 19(1):256. PubMed ID: 34112180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
    Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
    J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting programmed death-ligand 1 expression level in non-small cell lung cancer using a combination of peritumoral and intratumoral radiomic features on computed tomography.
    Shiinoki T; Fujimoto K; Kawazoe Y; Yuasa Y; Kajima M; Manabe Y; Ono T; Hirano T; Matsunaga K; Tanaka H
    Biomed Phys Eng Express; 2022 Feb; 8(2):. PubMed ID: 35051908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma.
    Gao R; Qin H; Lin P; Ma C; Li C; Wen R; Huang J; Wan D; Wen D; Liang Y; Huang J; Li X; Wang X; Chen G; He Y; Yang H
    Front Oncol; 2021; 11():613668. PubMed ID: 34295804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
    Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
    Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a radiomic-clinical nomogram for prediction of survival in patients with serous ovarian cancer.
    Hong Y; Liu Z; Lin D; Peng J; Yuan Q; Zeng Y; Wang X; Luo C
    Clin Radiol; 2022 May; 77(5):352-359. PubMed ID: 35264303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling regulatory T lymphocytes within the tumor microenvironment of breast cancer via radiomics.
    Jiang W; Wu R; Yang T; Yu S; Xing W
    Cancer Med; 2023 Dec; 12(24):21861-21872. PubMed ID: 38083903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
    Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
    Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seeing beyond the tumor: computed tomography image-based radiomic analysis helps identify ovarian clear cell carcinoma subtype in epithelial ovarian cancer.
    Ren J; Mao L; Zhao J; Li XL; Wang C; Liu XY; Jin ZY; He YL; Li Y; Xue HD
    Radiol Med; 2023 Aug; 128(8):900-911. PubMed ID: 37368228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
    Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
    Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radiomic nomogram based on arterial phase of CT for differential diagnosis of ovarian cancer.
    Hu Y; Weng Q; Xia H; Chen T; Kong C; Chen W; Pang P; Xu M; Lu C; Ji J
    Abdom Radiol (NY); 2021 Jun; 46(6):2384-2392. PubMed ID: 34086094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative computed tomography-guided disease-free survival prediction in gastric cancer: a multicenter radiomics study.
    Wang S; Feng C; Dong D; Li H; Zhou J; Ye Y; Liu Z; Tian J; Wang Y
    Med Phys; 2020 Oct; 47(10):4862-4871. PubMed ID: 32592224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomography-based radiomic analysis for prediction of treatment response to salvage chemoradiotherapy for locoregional lymph node recurrence after curative esophagectomy.
    Gu L; Liu Y; Guo X; Tian Y; Ye H; Zhou S; Gao F
    J Appl Clin Med Phys; 2021 Nov; 22(11):71-79. PubMed ID: 34614265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Radiomic Approach to Evaluate Tumor-Infiltrating CD8
    Liao H; Zhang Z; Chen J; Liao M; Xu L; Wu Z; Yuan K; Song B; Zeng Y
    Ann Surg Oncol; 2019 Dec; 26(13):4537-4547. PubMed ID: 31520208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.